These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 23208127

  • 21. Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy.
    Palmieri F, Brunocilla E, Bertaccini A, Guidi M, Pernetti R, Morselli-Labate AM, Martorana G.
    Anticancer Res; 2010 Jul; 30(7):2973-6. PubMed ID: 20683041
    [Abstract] [Full Text] [Related]

  • 22. Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder.
    Kassouf W, Svatek RS, Shariat SF, Novara G, Lerner SP, Fradet Y, Bastian PJ, Aprikian A, Karakiewicz PI, Fritsche HM, Dinney CP, Tilki D, Kamat AM, Izawa JI, Ficarra V, Lotan Y, Sagalowsky AI, Schoenberg MP, Skinner EC.
    Urol Oncol; 2013 May; 31(4):480-6. PubMed ID: 21478035
    [Abstract] [Full Text] [Related]

  • 23. Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients.
    Morgan TM, Barocas DA, Penson DF, Chang SS, Ni S, Clark PE, Smith JA, Cookson MS.
    Urology; 2012 Sep; 80(3):632-40. PubMed ID: 22795379
    [Abstract] [Full Text] [Related]

  • 24. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI.
    J Clin Oncol; 2005 Sep 20; 23(27):6533-9. PubMed ID: 16116151
    [Abstract] [Full Text] [Related]

  • 25. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
    Kassouf W, Agarwal PK, Herr HW, Munsell MF, Spiess PE, Brown GA, Pisters L, Grossman HB, Dinney CP, Kamat AM.
    J Clin Oncol; 2008 Jan 01; 26(1):121-6. PubMed ID: 18165646
    [Abstract] [Full Text] [Related]

  • 26. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J, Park S, Song C, Doo C, Cho YM, Ahn H, Kim CS.
    Urology; 2007 Aug 01; 70(2):257-62. PubMed ID: 17826485
    [Abstract] [Full Text] [Related]

  • 27. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
    Tilki D, Shariat SF, Lotan Y, Rink M, Karakiewicz PI, Schoenberg MP, Lerner SP, Sonpavde G, Sagalowsky AI, Gupta A.
    BJU Int; 2013 Jun 01; 111(8):1215-21. PubMed ID: 23181623
    [Abstract] [Full Text] [Related]

  • 28. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.
    Bruins HM, Huang GJ, Cai J, Skinner DG, Stein JP, Penson DF.
    J Urol; 2009 Nov 01; 182(5):2182-7. PubMed ID: 19758623
    [Abstract] [Full Text] [Related]

  • 29. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis.
    Abdel-Latif M, Abol-Enein H, El-Baz M, Ghoneim MA.
    J Urol; 2004 Jul 01; 172(1):85-9. PubMed ID: 15201743
    [Abstract] [Full Text] [Related]

  • 30. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
    Lee D, Yoo S, You D, Hong B, Cho YM, Hong JH, Kim CS, Ahn H, Ro JY, Jeong IG.
    Urol Oncol; 2017 Apr 01; 35(4):151.e1-151.e7. PubMed ID: 28139370
    [Abstract] [Full Text] [Related]

  • 31. Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy.
    Xylinas E, Rink M, Novara G, Green DA, Clozel T, Fritsche HM, Guillonneau B, Lotan Y, Kassouf W, Tilki D, Babjuk M, Karakiewicz PI, Montorsi F, Abdennabi J, Trinh QD, Svatek RS, Scherr DS, Zerbib M, Shariat SF.
    Ann Surg Oncol; 2013 Mar 01; 20(3):1027-34. PubMed ID: 23099729
    [Abstract] [Full Text] [Related]

  • 32. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy.
    May M, Herrmann E, Bolenz C, Brookman-May S, Tiemann A, Moritz R, Fritsche HM, Burger M, Trojan L, Michel MS, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Bastian PJ.
    Ann Surg Oncol; 2011 Jul 01; 18(7):2018-25. PubMed ID: 21246405
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy.
    Kassouf W, Leibovici D, Munsell MF, Dinney CP, Grossman HB, Kamat AM.
    J Urol; 2006 Jul 01; 176(1):53-7; discussion 57. PubMed ID: 16753366
    [Abstract] [Full Text] [Related]

  • 34. Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study.
    Dorin RP, Daneshmand S, Eisenberg MS, Chandrasoma S, Cai J, Miranda G, Nichols PW, Skinner DG, Skinner EC.
    Eur Urol; 2011 Nov 01; 60(5):946-52. PubMed ID: 21802833
    [Abstract] [Full Text] [Related]

  • 35. Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy.
    Bruins HM, Dorin RP, Rubino B, Miranda G, Cai J, Daneshmand S, Skinner EC.
    Eur Urol; 2012 Oct 01; 62(4):671-6. PubMed ID: 22575915
    [Abstract] [Full Text] [Related]

  • 36. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
    May M, Nitzke T, Helke C, Vogler H, Hoschke B.
    Scand J Urol Nephrol; 2004 Oct 01; 38(3):231-5. PubMed ID: 15204377
    [Abstract] [Full Text] [Related]

  • 37. Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy.
    May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM, Burger M, Buchner A, Gratzke C, Wülfing C, Trojan L, Ellinger J, Tilki D, Gilfrich C, Höfner T, Roigas J, Zacharias M, Gunia S, Wieland WF, Hohenfellner M, Michel MS, Haferkamp A, Müller SC, Stief CG, Bastian PJ.
    Eur Urol; 2011 May 01; 59(5):712-8. PubMed ID: 21296488
    [Abstract] [Full Text] [Related]

  • 38. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival.
    Jensen JB, Ulhøi BP, Jensen KM.
    Int J Urol; 2012 Jan 01; 19(1):39-47. PubMed ID: 22050425
    [Abstract] [Full Text] [Related]

  • 39. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Chang SS.
    J Urol; 2009 Feb 01; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [Abstract] [Full Text] [Related]

  • 40. Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer.
    Stephenson AJ, Gong MC, Campbell SC, Fergany AF, Hansel DE.
    Urology; 2010 Feb 01; 75(2):382-6. PubMed ID: 19819539
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.